Tenofovir DF vs. Adefovir Dipivoxil Chronic Hepatitis

ID Number 05-0594

Principal Investigator(s)
Joseph A Odin

Department(s) or Division(s)
Liver Diseases

Description

The purpose of this study is to compare the safety and the effectiveness of tenofovir DF (TDF) to that of adefovir dipivoxil (ADV) in patients chronically infected with hepatitis B virus (HBV).



Contact Information
Joseph A. Odin, MD
joseph.odin@mountsinai.org

Recruiting Patients: No